Prospective Evaluation of Remote Software Based Surveillance Supplementing Clinical Monitoring for Haemodialysis Vascular Access
Nephron · 20.01.2025 · 149 (6) · 324-332
DOI: 10.1159/000543609 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nephron, online erschienen am 20.01.2025. Verfasst von Alshymaa Rafiek Eltahan und 11 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine and Nephrology Department, Faculty of Medicine, Helwan University, Cairo, Egypt, alshymaaeltahan@gmail.com. Hauptthemen laut MEDLINE: Renal Dialysis, Arteriovenous Shunt, Surgical, Software. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Efficient arteriovenous vascular access (VA) surveillance is vital for early identification of dysfunctional access, allowing timely intervention to prevent thrombosis. This study compares the efficacy of adding remote software surveillance to standard clinical care across our units.
Methods
We conducted a 12-month prospective study on maintenance haemodialysis (HD) patients using Vasc-Alert software technology to assist clinical decision-making in 2 satellite HD units (group 1) and standard care in the remaining 3 HD units (group 2). Patients with Vasc-Alert-derived high Access Risk Score (ARS) (≥7) underwent clinical assessment and were referred for fistulogram based on relevant Kidney Disease Outcome Quality Initiative (KDOQI) criteria. Data on referrals for fistulogram, subsequent VA events, access abandonment, and complication-free days-extended (CFD-extended) were collected. VA survival analysis of post-intervention primary patency rate at 3 and 6 months was conducted.
Results
There were 23 (28.1%) pre-emptive correction of stenosis and 6 (7.3%) thrombosis episodes in group 1, compared to 40 (19.5%) and 21 (10.2%) in group 2 (p value 0.155, 0.587), respectively). Among the thrombotic episodes, 83% of cases in group 1 had been detected during surveillance and referred for diagnostic fistulogram ± angioplasty but developed thrombosis while awaiting elective intervention compared to 19% in group 2 (p = 0.004). Median time from fistulogram request to thrombosed VA was 26 days (interquartile range: 21–42 days). Group 1 exhibited better post-intervention primary patency rates and longer CFD compared to group 2 (p value
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Internal Medicine and Nephrology Department, Faculty of Medicine, Helwan University, Cairo, Egypt, alshymaaeltahan@gmail.com.
- Renal Department, Northern Care Alliance NHS Foundation Trust, Salford Care Organization, Greater Manchester, UK, alshymaaeltahan@gmail.com.
- Renal Department, Northern Care Alliance NHS Foundation Trust, Salford Care Organization, Greater Manchester, UK.
- Division of Cardiovascular Sciences, University of Manchester, Greater Manchester, UK.
- Finance Department, Northern Care Alliance NHS Foundation Trust, Salford Care Organization, Greater Manchester, UK.
Zitieren
APA
Eltahan, A. R., Pondor, Z., Donne, R. L., Lewis, D., Raman, M., Cowperthwaite, J., Resiga, M. L., Hinchliffe, P., Lim, J., Gleave, P., Allsopp, J., & Poulikakos, D. (2025). Prospective Evaluation of Remote Software Based Surveillance Supplementing Clinical Monitoring for Haemodialysis Vascular Access. Nephron, 149(6), 324-332. https://doi.org/10.1159/000543609
Vancouver
Eltahan AR, Pondor Z, Donne RL, Lewis D, Raman M, Cowperthwaite J, et al. Prospective Evaluation of Remote Software Based Surveillance Supplementing Clinical Monitoring for Haemodialysis Vascular Access. Nephron. 2025;149(6):324-332. doi:10.1159/000543609
BibTeX
@article{Eltahan2025,
author = {Eltahan, Alshymaa Rafiek and Pondor, Zulfikar and Donne, Rosemary L and Lewis, David and Raman, Maharajan and Cowperthwaite, Jan and Resiga, Marinela Liliana and Hinchliffe, Paul and Lim, Jazzle and Gleave, Paula and Allsopp, Jonathan and Poulikakos, Dimitrios},
title = {Prospective Evaluation of Remote Software Based Surveillance Supplementing Clinical Monitoring for Haemodialysis Vascular Access},
journal = {Nephron},
year = {2025},
volume = {149},
number = {6},
pages = {324--332},
doi = {10.1159/000543609}
}
EUVIMED